CEO's use of Eli Lilly's (LLY) weight loss drug Mounjaro over Novo Nordisk's (NVO) rival product, Ozempic. Read more here.
The first medication for obstructive sleep apnea has been approved by the US Food and Drug Administration (FDA).
GlobalData tracks drug-specific phase transition and likelihood of approval scores, in addition to indication benchmarks based off 18 years of historical drug development data. Attributes of the drug, ...
The US Food and Drug Administration has approved Zepbound (tirzepatide) as the first prescription medication for the treatment of obstructive sleep apnea (OSA).
An international committee of experts will release an interim report in early 2025 outlining criteria for diagnosing ...
California’s Medicaid program spent the most of all states on GLP-1 coverage, exceeding $1.4 billion, or $118 per enrollee.
Global pharma giant Eli Lilly plans to launch its diabetes and obesity treatment, tirzepatide, marketed under the brands ...
Hosted on MSN3h
Did You See Leaner Elon Musk In XMas Post? All About The Weight-Loss Drug He Claims To UseWhatever Elon Musk, the CEO of Tesla and SpaceX, says, dons, or does becomes news. On Christmas Day, the man who is the force ...
The latest health news includes WuXi's sale of its Advanced Therapies unit due to US restrictions, expanding famine in Sudan ...
The project aims to attract more visitors to the Miller Woods, Paul H. Douglas Center for Environmental Education and Gary's Miller neighborhood on the west end of the park and the Mount Baldy Beach ...
Taxi jumps curb, slams into Christmas Day crowd outside Manhattan Macy’s on W. 34th St. A taxi cab jumped the curb and slammed into six pedestrians walking near Macy's on W. 34th St. and Sixth ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback